about
A review of nebulized drug delivery in COPDProbing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling.24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD.Importance of GOLD Guidelines for Chronic Obstructive Pulmonary Disease.A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Positioning new pharmacotherapies for COPD
@ast
Positioning new pharmacotherapies for COPD
@en
Positioning new pharmacotherapies for COPD
@nl
type
label
Positioning new pharmacotherapies for COPD
@ast
Positioning new pharmacotherapies for COPD
@en
Positioning new pharmacotherapies for COPD
@nl
prefLabel
Positioning new pharmacotherapies for COPD
@ast
Positioning new pharmacotherapies for COPD
@en
Positioning new pharmacotherapies for COPD
@nl
P2093
P2860
P921
P3181
P356
P1476
Positioning new pharmacotherapies for COPD
@en
P2093
Anthony F Arredondo
Christopher B Cooper
Igor Z Barjaktarevic
P2860
P304
P3181
P356
10.2147/COPD.S83758
P407
P577
2015-01-01T00:00:00Z
2015-07-24T00:00:00Z